20/20 BioLabs and IBM collaboration signals new direction in preventive diagnostics
20/20 BioLabs launches AI-powered OneTest for longevity risk modeling. Discover what this means for preventive diagnostics and regulation.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
What InventHelp’s heat therapy mitten reveals about the limits of consumer pain devices
InventHelp’s heat therapy mitten targets hand pain, but what does it really change? Explore the evidence, regulatory gaps, and limits of consumer pain devices.
Medical Devices & Diagnostics
What Guerbet’s pediatric gadopiclenol label expansion reveals about the future of MRI contrast agents
FDA approval expands Guerbet’s gadopiclenol into neonates, reinforcing half-dose MRI contrast strategies. Find out what this changes for pediatric imaging.
Medical Devices & Diagnostics
Why Edwards Lifesciences is betting on transcatheter replacement to solve tricuspid regurgitation
Find out how transcatheter tricuspid valve replacement is reshaping treatment options for severe regurgitation and what clinicians are watching next.
Medical Devices & Diagnostics
What Lake Forest Regenesis’s Emsculpt NEO launch reveals about the future of device-led metabolic care
Lake Forest Regenesis launches Emsculpt NEO and Emsella. Discover what this means for noninvasive devices, regulation, and clinical adoption.
Medical Devices & Diagnostics
Why GE HealthCare’s FDA-cleared SIGNA MRI update is more about operations than image quality
GE HealthCare’s FDA-cleared SIGNA MRI systems signal a shift toward autonomous, helium-free imaging. Explore what this means for MRI operations.
Medical Devices & Diagnostics
What Belay Diagnostics’ Summit 2.0 results reveal about the future of CNS molecular diagnostics
Belay Diagnostics validates its Summit 2.0 CSF genomic assay, strengthening the clinical case for liquid biopsy in CNS cancers. Read the full analysis.
Medical Devices & Diagnostics
Why Sibel Health’s Aria sensor could change endpoint design in chronic refractory cough trials
Sibel Health secures FDA acceptance for its Aria cough sensor. Find out what this could change for chronic cough drug trials and digital endpoints.
Medical Devices & Diagnostics
Merlin CP-GEP becomes first NCCN-endorsed molecular test for early-stage melanoma risk assessment
NCCN guidelines now recommend Merlin CP-GEP for early-stage melanoma risk assessment. Discover what this changes for clinicians and diagnostics adoption.
Medical Devices & Diagnostics
Bimini Health Tech strengthens Puregraft franchise with SYNC as fat grafting scales globally
Bimini Health Tech secures FDA clearance for Puregraft SYNC. Explore what it changes for fat grafting workflows, adoption economics, and device strategy.